Related Experiment Videos
Metachromatic leukodystrophy among southern Alaskan Eskimos: molecular and genetic studies
N M Pastor-Soler1, E M Schertz, M A Rafi
1Department of Medicine (Medical Genetics), Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Abstract:
Metachromatic leukodystrophy (MLD) is an autosomal recessive disorder resulting from the inability to metabolize sulphatide, an important component of myelin. Although there is significant clinical variability between patients, most have the late-infantile form. It is one of the most common lysosomal disorders involving mental deterioration and is found throughout the world. The great majority of the cases have a deficiency of arylsulphatase A activity. Accurate diagnosis of MLD is complicated by the presence of so-called pseudodeficiency alleles and the need to receive specimens for biochemical testing within 24-48 h of collection. We report the identification of the mutation (a g-to-a transition in the first nucleotide of intron 4) in the arylsulphatase A gene causing late-infantile MLD among the Eskimo population of southern Alaska. As all patients and family members from living and deceased patients had the same mutation, a mutation-based test was developed to identify patients and carriers that can be done on dried blood spots sent via regular mail service. A possible genetic link between this population and the Navajo Indians of the southwestern United States is proposed.
Insights
Metachromatic leukodystrophy (MLD) diagnosis is improved by identifying a specific arylsulphatase A gene mutation in Alaskan Eskimos. This discovery enables a new, mail-service-compatible genetic test for patients and carriers.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- Metachromatic leukodystrophy (MLD) is a rare, inherited lysosomal disorder affecting myelin metabolism.
- It typically involves arylsulphatase A deficiency and leads to progressive neurological deterioration.
- Accurate MLD diagnosis is challenging due to pseudodeficiency alleles and sample transport requirements.
Purpose of the Study:
- To identify the genetic cause of late-infantile MLD in the Alaskan Eskimo population.
- To develop a mutation-based diagnostic test for MLD suitable for remote populations.
Main Methods:
- Genetic sequencing to identify mutations in the arylsulphatase A gene.
- Development of a mutation-specific diagnostic assay.
- Analysis of patient and family DNA samples.
Main Results:
- A specific g-to-a transition mutation in intron 4 of the arylsulphatase A gene was identified as the cause of MLD in this population.
- All analyzed patients and family members shared this mutation.
- A mutation-based test using dried blood spots was successfully developed.
Conclusions:
- The identified mutation provides a specific genetic marker for MLD in Alaskan Eskimos.
- The developed test simplifies diagnosis and carrier screening, overcoming previous logistical hurdles.
- A potential genetic link between this population and Navajo Indians warrants further investigation.